Gateway 2011: Magnetrol - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011: Magnetrol


Your online Gateway to Magnetrol International, Incorporated, in 2011


MagnetrolLogo


5300 Belmont Road
Downers Grove, Illinois 60515
magnetrol.com

 

About us
Magnetrol hygienic level and flow instrumentation is found throughout the pharmaceutical, bio-technology, and food and beverage markets. Product quality is maintained by the design and implementation of effective hygienic process controls, of which level and flow instruments form an integral part.

Magnetrol hygienic instruments are engineered to provide measurement solutions that are in the forefront of level and flow technology, solutions with an industry wide reputation for robust construction, trouble-free set up and operation, and a fast return on your investment.

Our products include Eclipse® guided wave radar transmitters, Pulsar® and Model R82 pulse burst radar transmitters, Echotel® ultrasonic switches and transmitters and Thermatel® thermal dispersion switches and transmitters.


Join Us at PACK EXPO 2011
Magnetrol looks forward to seeing you in booth 6815 located in the Processing Zone in the Upper South Hall.We will be displaying our Eclipse® Model 705 Guided Wave Radar transmitter, Echotel® Models 960 and 961 Ultrasonic level switches, and Thermatel® Model TD2 Flow & Level switches.


Magnetrol2

New Products and Releases

Food and Beverage Industry Brochure

Life Science Industry Brochure

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here